Evidence map›Paper›PMID 41833958›Full record

ArticleScientific reports2026

Hydrogen production from NaBH₄ hydrolysis over chemically reduced TiO₂-based Ru nanocomposites and their antimicrobial performance.

Ebru Halvacı, Farah Mutlag, Hussein Elaibi, Fatih Sen

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ebru HalvacıSen Research Group, Department of Biochemistry, Dumlupinar University, 43000, Kutahya, Turkey.
Farah MutlagSen Research Group, Department of Biochemistry, Dumlupinar University, 43000, Kutahya, Turkey.
Hussein ElaibiSen Research Group, Department of Biochemistry, Dumlupinar University, 43000, Kutahya, Turkey.
Fatih SenSen Research Group, Department of Biochemistry, Dumlupinar University, 43000, Kutahya, Turkey. fatihsen1980@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, Ru⁰/TiO₂ nanocomposites containing 0.5 wt% Ru were prepared via a simple wet-impregnation route followed by chemical reduction and were thoroughly characterized by XRD, FTIR, SEM, TEM, and EDS analyses. The nanocomposite exhibits high activity toward the hydrolysis of NaBH₄ in water under relatively mild conditions (300 mM NaBH₄, without added base). Systematic variation of NaBH₄ concentration and catalyst loading shows that the hydrogen generation rate is essentially first order in both NaBH₄ and Ru⁰/TiO₂, yielding hydrogen generation rates in the range of ≈ 335.6 mL·min⁻¹·g_cat⁻¹ and turnover frequencies (TOF) of ≈ 938.30 h⁻¹ between 25 and 40 °C. Temperature-dependent kinetic measurements afforded an apparent activation energy of 32.37 kJ·mol⁻¹ together with ΔH‡ = 29.82 kJ·mol⁻¹ and ΔS‡ = -143 J·mol⁻¹·K⁻¹, indicating an energetically accessible yet highly ordered transition state at the Ru/TiO₂ interface. The catalyst retains ~ 36% activity after 4 cycles. In addition, Ru⁰/TiO₂ nanocomposites display strong antibacterial activity against both Gram-positive and Gram-negative bacteria, achieving growth inhibition above 90% at 500 µg·mL⁻¹. The dual functionality of Ru⁰/TiO₂ in highly efficient NaBH₄ hydrolysis and pronounced antimicrobial behavior highlights this nanocomposite as a versatile platform for practical chemical hydrogen storage and integrated energy and environmental applications.

Indexed as

Anti-Infective AgentsBorohydridesHydrogenNanocompositesRutheniumTitaniumCatalysisHydrolysisKineticsAnti-Infective AgentsBorohydridesHydrogenRutheniumsodium borohydrideTitaniumtitanium dioxideInterfacial catalysisMetal-support interactionNaBH₄ hydrolysisRu-based nanocomposites

Identifiers

PMID41833958
PMCPMC13121615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.